Optimum dose range for the amelioration of long term radiation-induced hyposalivation using prophylactic pilocarpine treatment

Radiotherapy and Oncology

Volumn 86, Issue 3, 2008, Pages 347-353

  Burlage, Fred Ronald ^a   Roesink, Judith M ^b   Faber, Hette ^a   Vissink, Arjan ^c   Langendijk, Johannes A ^a   Kampinga, Harm H ^a   Coppes, Rob P ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Parotid gland; Pilocarpine; Radiation induced damage; Radioprotection

Indexed keywords

PILOCARPINE;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPOSALIVATION; MALE; NONHUMAN; PAROTID GLAND; PRIORITY JOURNAL; PROPHYLAXIS; RADIATION DOSE; RADIATION INJURY; RADIATION PROTECTION; RAT; TREATMENT RESPONSE;

ANIMALS; MALE; MUSCARINIC ANTAGONISTS; PAROTID GLAND; PILOCARPINE; RADIATION INJURIES, EXPERIMENTAL; RATS; RATS, WISTAR; SALIVATION; XEROSTOMIA;

EID: 40249109861     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.10.011     Document Type: Article

References (31)

1. Vissink A., Jansma J., Spijkervet F.K., et al. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 14 (2003) 199-212
2. Jensen A.B., Hansen O., Jorgensen K., et al. Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer. Acta Oncol 33 (1994) 487-491
3. Konings A.W., Coppes R.P., and Vissink A. On the mechanism of salivary gland radiosensitivity. Int J Radiat Oncol Biol Phys 62 (2005) 1187-1194
4. Vissink A., Burlage F.R., Spijkervet F.K., et al. Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med 14 (2003) 213-225
5. Coppes R.P., Zeilstra L.J., Vissink A., et al. Sialogogue-related radioprotection of salivary gland function: the degranulation concept revisited. Radiat Res 148 (1997) 240-247
6. Sagowski C., Wenzel S., Metternich F.U., et al. Studies on the radioprotective potency of amifostine on salivary glands of rats during fractionated irradiation: acute and late effects. Eur Arch Otorhinolaryngol 260 (2003) 42-47
7. Epperly M.W., Carpenter M., Agarwal A., et al. Intraoral manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) radioprotective gene therapy decreases ionizing irradiation-induced murine mucosal cell cycling and apoptosis. In Vivo 18 (2004) 401-410
8. Hakim S.G., Kosmehl H., Lauer I., et al. A comparative study on the protection profile of lidocaine, amifostine, and pilocarpin on the parotid gland during radiotherapy. Cancer Res 65 (2005) 10486-10493
9. Konings A.W., Faber H., Vissink A., et al. Radioprotective effect of amifostine on parotid gland functioning is region dependent. Int J Radiat Oncol Biol Phys 63 (2005) 1584-1591
10. Coppes R.P., Vissink A., Zeilstra L.J., et al. Muscarinic receptor stimulation increases tolerance of rat salivary gland function to radiation damage. Int J Radiat Biol 72 (1997) 615-625
11. Roesink J.M., Konings A.W., Terhaard C.H., et al. Preservation of the rat parotid gland function after radiation by prophylactic pilocarpine treatment: radiation dose dependency and compensatory mechanisms. Int J Radiat Oncol Biol Phys 45 (1999) 483-489
12. Coppes R.P., Zeilstra L.J., Kampinga H.H., et al. Early to late sparing of radiation damage to the parotid gland by adrenergic and muscarinic receptor agonists. Br J Cancer 85 (2001) 1055-1063
13. Burlage FR, Roesink JM, Kampinga HH et al. Protection of salivary function by concomitant pilocarpine during radiotherapy; a double-blind randomized, placebo controlled study. Int J Radiat Oncol Biol Phys 2007 Sep 13; [Epub ahead of print].
14. Eisbruch A., Ship J.A., Dawson L.A., et al. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg 27 (2003) 832-837
15. Malouf J.G., Aragon C., Henson B.S., et al. Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients. Cancer Detect Prev 27 (2003) 305-310
16. Braam P.M., Terhaard C.H.J., Roesink J.M., and Raaijmakers P.J. Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 975-980
17. Chao K.S.C., Deasy J.O., Markman J., et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 49 (2001) 907-916
18. Vissink A., Gravenmade E.J., Konings A.W., et al. An adaptation of the Lashley cup for use in rat saliva collection. Arch Oral Biol 34 (1989) 577-578
19. Coppes R.P., Vissink A., and Konings A.W. Comparison of radiosensitivity of rat parotid and submandibular glands after different radiation schedules. Radiother Oncol 63 (2002) 321-328
20. Coppes R.P., Roffel A.F., Zeilstra L.J., et al. Early radiation effects on muscarinic receptor-induced secretory responsiveness of the parotid gland in the freely moving rat. Radiat Res 153 (2000) 339-346
21. Kim K.H., Kim J.Y., Sung M.W., et al. The effect of pilocarpine and atropine administration on radiation-induced injury of rat submandibular glands. Acta Otolaryngol 111 (1991) 967-973
22. +-ATPase activity. Am J Physiol Cell Physiol 290 (2006) C702-C710
23. Burford-Mason A.P., Cummins M.M., Brown D.H., et al. Immunohistochemical analysis of the proliferative capacity of duct and acinar cells during ligation-induced atrophy and subsequent regeneration of rat parotid gland. J Oral Pathol Med 22 (1993) 440-446
24. Lombaert I.M., Wierenga P.K., Kok T., et al. Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glands. Clin Cancer Res 12 (2006) 1804-1812
25. Gornitsky M., Shenouda G., Sultanem K., et al. Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 (2004) 45-52
26. Warde P., O'Sullivan B., Aslanidis J., et al. A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 54 (2002) 9-13
27. Haddad P., and Karimi M. A randomized, double-blind, placebo-controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia. Radiother Oncol 64 (2002) 29-32
28. Lajtman Z., Krajina Z., Krpan D., et al. Pilocarpine in the prevention of postirradiation xerostomia. Acta Med Croatica 54 (2000) 65-67
29. Sangthawan D., Watthanaarpornchai S., and Phungrassami T. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia. J Med Assoc Thai 84 (2001) 195-203
30. Zimmerman R.P., Mark R.J., Tran L.M., et al. Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia. Int J Radiat Oncol Biol Phys 37 (1997) 571-575
31. Scarantino C., LeVEque F., Swann R.S., White R., Schulsinger A., Hodson D.I., et al. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients. J Support Oncol 4 (2006) 252-258